Answers are grounded in this paper and cite their sources.
Significance Osteoporosis and sarcopenia are common and costly comorbid diseases of aging, and there is an urgent need to prevent and treat both to reduce morbidity and mortality. We found that, in humans, genetic variation near FAM210A , a gene of previously unknown function, was strongly associated with both appendicular and whole body lean mass, as well as bone mineral density. In mice, Fam210a was expressed in muscle mitochondria and cytoplasm but not in bone. Nevertheless, in genetically modified mouse models, Fam210a strongly influenced the structure and strength of both muscle and bone. These studies therefore disclose a novel pathway whose further study may lead to the development of new treatments for both osteoporosis and sarcopenia.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: